Skip to main content
Year archive

RACURA ONCOLOGY LTD — 2023 filings

All 89 regulatory filings released by RACURA ONCOLOGY LTD (RAC) in 2023, sourced directly from the official regulator.

89 Filings
2023 Period
2023 filings (89)
Filing Released Lang
December 2023 Preclinical & Clinical Program Update 5 pages 374.4KB
Capital/Financing Update
2023-12-28 English
Application for quotation of securities - RAC 8 pages 30.4KB
Share Issue/Capital Change
2023-12-27 English
Notification regarding unquoted securities - RAC 9 pages 31.7KB
Capital/Financing Update
2023-12-27 English
Application for quotation of securities - RAC 8 pages 30.4KB
Share Issue/Capital Change
2023-12-20 English
Notification regarding unquoted securities - RAC 9 pages 31.7KB
Capital/Financing Update
2023-12-20 English
Application for quotation of securities - RAC 8 pages 30.3KB
Share Issue/Capital Change
2023-12-13 English
Notification regarding unquoted securities - RAC 9 pages 33.7KB
Share Issue/Capital Change
2023-12-13 English
Bisantrene Phase 2 AML data presented at ASH conference 3 pages 753.4KB
Investor Presentation
2023-12-12 English
Notification regarding unquoted securities - RAC 7 pages 28.9KB
Capital/Financing Update
2023-12-03 English
Appendix 3Y-Mary Harney 2 pages 233.4KB
Director's Dealing
2023-12-03 English
Appendix 3Y-Phillip Lynch 2 pages 233.7KB
Director's Dealing
2023-12-03 English
Notification regarding unquoted securities - RAC 9 pages 33.9KB
Share Issue/Capital Change
2023-11-30 English
Appendix 3Y-Mary Harney 2 pages 232.6KB
Director's Dealing
2023-11-30 English
Appendix 3Y-Peter Smith 2 pages 229.6KB
Director's Dealing
2023-11-30 English
New Zealand Investor Information 2 pages 258.9KB
Capital/Financing Update
2023-11-28 English
Notification regarding unquoted securities - RAC 10 pages 38.7KB
Share Issue/Capital Change
2023-11-28 English
Race Oncology 2023 Chair's Address & AGM Presentation 26 pages 1.2MB
AGM Information
2023-11-26 English
Results of Annual General Meeting 2 pages 302.6KB
Declaration of Voting Results & Voting Rights Announcements
2023-11-26 English
Dr Daniel Tillett appointed CEO of Race Oncology 3 pages 321.8KB
Board/Management Information
2023-11-21 English
Updated Strategy and Investor Presentation 51 pages 2.4MB
Investor Presentation
2023-11-21 English
Race Investor Briefing Invitation 2 pages 282.2KB
Investor Presentation
2023-11-21 English
Bonus Options Prospectus 39 pages 590.7KB
Share Issue/Capital Change
2023-11-21 English
Proposed issue of securities - RAC 6 pages 32.7KB
Share Issue/Capital Change
2023-11-21 English
Replacement Race Investor Briefing Invitation 2 pages 281.1KB
Regulatory Filings
2023-11-21 English
Notification regarding unquoted securities - RAC 8 pages 34.4KB
Share Issue/Capital Change
2023-11-20 English
RC220 Meets Quality Specifications 3 pages 346.0KB
Capital/Financing Update
2023-11-08 English
Release of Securities from Voluntary Escrow 1 page
Share Issue/Capital Change
2023-11-05 English
Impressive Bisantrene Phase 2 AML Clinical Results 6 pages 962.9KB
Capital/Financing Update
2023-11-05 English
Trading Halt 2 pages 364.1KB
Regulatory Filings
2023-11-02 English
Notification regarding unquoted securities - RAC 8 pages 35.2KB
Share Issue/Capital Change
2023-10-31 English
Letter to Shareholders, Notice of AGM & Proxy Form 26 pages 1.4MB
AGM Information
2023-10-24 English
Annual Report to Shareholders 66 pages 1.6MB
Annual Report FY 2023
2023-10-24 English
Quarterly Activity Report & Appendix 4C 10 pages 611.8KB
Interim / Quarterly Report Q1 2024
2023-10-22 English
RC220 Peripheral Infusion Safety Confirmed 3 pages 311.0KB
Regulatory Filings
2023-10-16 English
Date of AGM and Closing Date for Director Nominations 1
AGM Information
2023-10-08 English
RC220 Toxicology and Safety Pharmacology Studies Initiated 3 pages 316.4KB
Capital/Financing Update
2023-10-04 English
Bisantrene cGMP API Manufacturing Completed at Laurus Labs 3 pages 319.1KB
Capital/Financing Update
2023-09-26 English
Bisantrene Shows Broad Anti-Cancer Activity in Cancer Cells 4 pages 343.3KB
Regulatory Filings
2023-09-20 English
Appendix 4E & Annual Report 68 pages 2.0MB
Annual Report FY 2023
2023-08-29 English
Corporate Governance Statement 19 pages 425.7KB
Governance Information
2023-08-29 English
Appendix 4G 13 pages 391.3KB
Regulatory Filings
2023-08-29 English
Race Board and Management Team Changes 3 pages 322.5KB
Board/Management Information
2023-08-21 English
Final Director's Interest Notice-Damian Clarke-Bruce 2 pages 290.3KB
Director's Dealing
2023-08-21 English
Final Director's Interest Notice-John Cullity 2 pages 292.1KB
Director's Dealing
2023-08-21 English
Notification of cessation of securities - RAC 4 pages 24.0KB
Share Issue/Capital Change
2023-08-21 English
Race Strategic Update August 2023 50 pages 5.9MB
Investor Presentation
2023-08-07 English
Race Investor Information Sessions 2 pages 382.5KB
Investor Presentation
2023-08-07 English
Quarterly Activity Report & Appendix 4C 12 pages 462.7KB
Interim / Quarterly Report Q4 2023
2023-07-30 English
Race Receives Additional $1.66m R&D Tax Refund for FY 2022 2 pages 108.3KB
Regulatory Filings
2023-07-12 English
Race executes agreement with Ardena for GMP manufacturing 3 pages 115.0KB
Capital/Financing Update
2023-07-11 English
Race global agreement with City of Hope to access FTO IP 4 pages 152.8KB
Capital/Financing Update
2023-07-09 English
H1 2023 Preclinical and Clinical Programs Update 5 pages 203.2KB
Capital/Financing Update
2023-07-06 English
Race Board Changes 2 pages 109.3KB
Board/Management Information
2023-06-28 English
Final Director's Interest Notice 2 pages 290.9KB
Director's Dealing
2023-06-28 English
Initial Director's Interest Notice 2 pages 169.2KB
Director's Dealing
2023-06-28 English
Proposed issue of securities - RAC 6 pages 30.5KB
Capital/Financing Update
2023-06-28 English
Notification of cessation of securities - RAC 4 pages 24.0KB
Regulatory Filings
2023-06-28 English
Race Completes On-Market Buy-Back Program 2 pages 78.3KB
Transaction in Own Shares
2023-06-21 English
Update - Notification of buy-back - RAC 6 pages 27.3KB
Transaction in Own Shares
2023-06-21 English
Letter to Shareholders 4 pages 107.7KB
Regulatory Filings
2023-06-14 English
Ceasing to be a substantial holder 2 pages 814.4KB
Major Shareholding Notification
2023-05-14 English
Application for quotation of securities - RAC 6 pages 28.1KB
Share Issue/Capital Change
2023-05-11 English
Cleansing Notice 1 page 75.4KB
Capital/Financing Update
2023-05-11 English
Race appoints Dr Michelle Rashford Chief Medical Officer 2 pages 143.0KB
Board/Management Information
2023-05-08 English
Quarterly Activity Report & Appendix 4C 14 pages 367.1KB
Interim / Quarterly Report Q3 2023
2023-04-27 English
Race continues Board renewal - appoints new Chair 2 pages 107.6KB
Board/Management Information
2023-04-19 English
Race releases complete cardio-protection data & video 40 pages 3.3MB
Investor Presentation
2023-04-13 English
Race releases cardioprotection market potential data 11 pages 631.9KB
Regulatory Filings
2023-04-03 English
Race Receives $1.48m R&D Tax Refund for Financial Year 2022 2 pages 86.3KB
Capital/Financing Update
2023-03-26 English
Race Leadership Changes 3 pages 111.6KB
Board/Management Information
2023-03-23 English
Final Director's Interest Notice - Dr Daniel Tillett 2 pages 278.3KB
Director's Dealing
2023-03-23 English
Pause in Trading 1 page 110.5KB
Regulatory Filings
2023-03-21 English
Trading Halt 2 pages 223.4KB
Board/Management Information
2023-03-21 English
Race Executes Contracts to Commence Breast Cancer Trial 2 pages 134.0KB
Regulatory Filings
2023-03-12 English
Notification regarding unquoted securities - RAC 8 pages 34.3KB
Share Issue/Capital Change
2023-03-02 English
Appendix 3Y x 3 6 pages 260.8KB
Director's Dealing
2023-03-02 English
Replacement Appendix 3Y - Damian Clarke Bruce 2 pages 212.8KB
Director's Dealing
2023-03-02 English
New Collaboration to Understand Zantrene Cardioprotection 3 pages 116.9KB
Regulatory Filings
2023-03-01 English
Appendix 4D & Half-Year Financial Statements 26 pages 747.9KB
Interim / Quarterly Report H1 2023
2023-02-26 English
Results of Meeting 2 pages 85.6KB
Declaration of Voting Results & Voting Rights Announcements
2023-02-20 English
Appendix 3Y - Dr Daniel Tillett 2 pages 178.5KB
Director's Dealing
2023-02-06 English
Application for quotation of securities - RAC 6 pages 28.0KB
Share Issue/Capital Change
2023-02-01 English
Cleansing Notice 1 page 124.2KB
Share Issue/Capital Change
2023-02-01 English
Appendix 3X - Damian Clarke-Bruce 2 pages 166.6KB
Director's Dealing
2023-01-31 English
Race Receives Cardioprotection Ethics Trial Approval 2 pages 131.6KB
Regulatory Filings
2023-01-31 English
Replacement Appendix 3X - Damian Clarke-Bruce 2 pages 166.6KB
Director's Dealing
2023-01-31 English
Quarterly Activity Report & Appendix 4C 11 pages 370.0KB
Interim / Quarterly Report Q2 2022
2023-01-30 English
Letter to Shareholders, Notice of Meeting & Proxy Form 27 pages 697.0KB
AGM Information
2023-01-18 English
Appendix 3Y - Dr Daniel Tillett 2 pages 178.8KB
Director's Dealing
2023-01-15 English